AfPA's Patient Access Podcast
Alliance for Patient Access
Add to My Podcasts
Episodes
About
Reviews
Promote
How ICER Misses What Matters
24 minutes
Posted Feb 20, 2020 at 8:54 pm.
0:00
24:09
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Gunnar Esiason, a cystic fibrosis advocate, explains why the Institute for Clinical and Economic Review’s model for determining drugs' value doesn't sit well with patients.
Previous
When Two is Better than One
Next
America's Heart Disease Crisis
← See all 27 episodes of AfPA's Patient Access Podcast